Related Experiment Video
Updated: Mar 22, 2026

07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
1.7K
Vaccines and IP Rights: A Multifaceted Relationship
1Miller Thomson, LLP, 40 King St. W., Suite 5800, Toronto, ON, Canada, M5H 3S1. kdurell@millerthomson.com.
Methods in Molecular Biology (Clifton, N.J.)
|April 15, 2016
Summary
Multiple intellectual property (IP) rights, including patents and trade secrets, can protect vaccines. An integrated IP strategy is crucial for effective vaccine development and distribution.
Area of Science:
- Biotechnology and Pharmaceutical Law
- Vaccinology
- Intellectual Property Law
Background:
- Vaccines involve complex compositions, delivery systems, and distribution networks.
- Existing discussions on vaccine intellectual property (IP) often focus narrowly on single IP rights.
Purpose of the Study:
- To advocate for a comprehensive approach to intellectual property (IP) protection for vaccines.
- To highlight the benefits of integrating multiple IP rights for vaccine development and distribution.
Main Methods:
- Analysis of various intellectual property (IP) rights applicable to vaccines.
- Examination of integrated IP strategies for vaccine development and distribution.
Main Results:
- Multiple IP rights, including patents, copyright, trademarks, plant breeders' rights, and trade secrets, are applicable to vaccines.
- An integrated IP strategy can enhance vaccine development and distribution.
Conclusions:
- A multifaceted IP approach is essential for optimizing vaccine innovation and accessibility.
- Considering diverse IP rights collectively offers significant advantages for the vaccine ecosystem.
Related Concept Videos
Vaccines
25
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
25
Vaccinations
53.4K
Overview
53.4K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccine Production
30
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
30
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Drug Products: Biologics, Biosimilars and Interchangeables
348
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
348

